Herpesvirus entry mediator is a serotype specific determinant of pathogenesis in ocular herpes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 50, 2012, Pages 20649-20654

  Karaba, Andrew H ^a   Kopp, Sarah J ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Eye infection; Herpes stromal keratitis; Viral eye disease; Viral pathogenesis

Indexed keywords

HERPESVIRUS ENTRY MEDIATOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; KERATITIS; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; OCULAR HERPES; PATHOGENESIS; PRIORITY JOURNAL; SEROTYPE; TRIGEMINUS GANGLION; VAGINA; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; CLASSIFICATION; DISEASE MODEL; FEMALE; GENETICS; GENITAL HERPES; HERPES SIMPLEX KERATITIS; HOST PATHOGEN INTERACTION; MOUSE MUTANT; PATHOGENICITY; PHYSIOLOGY; SEROTYPING; SPECIES DIFFERENCE; VIROLOGY; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HOST-PATHOGEN INTERACTIONS; KERATITIS, HERPETIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SEROTYPING; SPECIES SPECIFICITY; VIRULENCE; VIRUS REPLICATION;

EID: 84874411785     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1216967109     Document Type: Article

References (41)

1. Xu F, et al. (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296(8):964–973.
2. Roberts CM, Pfister JR, Spear SJ (2003) Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 30(10):797–800.
3. Ross JD, Smith IW, Elton RA (1993) The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978–1991. Genitourin Med 69(5):381–383.
4. Roizman B, Knipe DM, Whitley RJ (2006) Fields’ Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia).
5. Rowe AM, et al.(2012) Herpes keratitis. Prog Retin Eye Res, 10.1016/j.preteyeres.2012.08.002.
6. Liesegang TJ (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20(1):1–13.
7. Young RC, Hodge DO, Liesegang TJ, Baratz KH (2010) Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: The effect of oral antiviral prophylaxis. Arch Ophthalmol 128(9):1178–1183.
8. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R (2011) Fusing structure and function: A structural view of the herpesvirus entry machinery. Nat Rev Microbiol 9(5):369–381.
9. Montgomery RI, Warner MS, Lum BJ, Spear PG (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87(3): 427–436.
10. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG (1998) Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280(5369):1618–1620.
11. Cocchi F, Menotti L, Mirandola P, Lopez M, Campadelli-Fiume G (1998) The ectodo-main of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells. J Virol 72(12):9992–10002.
12. Shukla D, et al. (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99(1):13–22.
13. Taylor JM, et al. (2007) Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe 2(1):19–28.
14. Kopp SJ, et al. (2009) Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1. Proc Natl Acad Sci USA 106(42):17916–17920.
15. Karaba AH, Kopp SJ, Longnecker R (2011) Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea. J Virol 85(19): 10041–10047.
16. Sciortino MT, et al. (2008) Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD. Biochem Pharmacol 76(11):1522–1532.
17. Sedý JR, Spear PG, Ware CF (2008) Cross-regulation between herpesviruses and the TNF superfamily members. Nat Rev Immunol 8(11):861–873.
18. Inagaki M, et al. (2005) Roles of cell-adhesion molecules nectin 1 and nectin 3 in ciliary body development. Development 132(7):1525–1537.
19. Ejercito PM, Kieff ED, Roizman B (1968) Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol 2(3): 357–364.
20. Rawls WE, Laurel D, Melnick JL, Glicksman JM, Kaufman RH (1968) A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Her-pesviruses with distinct antigenic properties. Am J Epidemiol 87(3):647–655.
21. Smith KO (1964) Relationship between the envelope and the infectivity of herpes simplex virus. Proc Soc Exp Biol Med 115:814–816.
22. Duff R, Rapp F (1971) Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J Virol 8(4):469–477.
23. Smith TJ, Ackland-Berglund CE, Leib DA (2000) Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J Virol 74(8):3598–3604.
24. Grau DR, Visalli RJ, Brandt CR (1989) Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence. Invest Ophthalmol Vis Sci 30(12):2474–2480.
25. Perng G-C, et al. (2002) Herpes simplex virus type 1 mutants containing the KOS strain ICP34.5 gene in place of the McKrae ICP34.5 gene have McKrae-like spontaneous reactivation but non-McKrae-like virulence. J Gen Virol 83(Pt 12):2933–2942.
26. Gordon YJ, et al. (1986) The development of an improved murine iontophoresis reactivation model for the study of HSV-1 latency. Invest Ophthalmol Vis Sci 27(8):1230–1234.
27. Szpara ML, Parsons L, Enquist LW (2010) Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations. J Virol 84(10):5303–5313.
28. Dix RD, McKendall RR, Baringer JR (1983) Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun 40(1):103–112.
29. Spear PG, et al. (2006) Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry. Virology 344(1):17–24.
30. Krummenacher C, et al. (2004) Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus. Virology 322(2):286–299.
31. Yoon M, Zago A, Shukla D, Spear PG (2003) Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1. J Virol 77(17):9221–9231.
32. Shukla D, Rowe CL, Dong Y, Racaniello VR, Spear PG (1999) The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J Virol 73(5):4493–4497.
33. Murphy TL, Murphy KM (2010) Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol 28:389–411.
34. Steinberg MW, Cheung TC, Ware CF (2011) The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol Rev 244(1):169–187.
35. Stiles KM, et al. (2010) Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition. J Virol 84(22):11646–11660.
36. Yoon M, et al. (2011) Functional interaction between herpes simplex virus type 2 gD and HVEM transiently dampens local chemokine production after murine mucosal infection. PLoS ONE 6(1):e16122.
37. Ritchie MH, Oakes JE, Lausch RN (1993) Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Invest Ophthalmol Vis Sci 34(8):2460–2468.
38. Terhune SS, Coleman KT, Sekulovich R, Burke RL, Spear PG (1998) Limited variability of glycoprotein gene sequences and neutralizing targets in herpes simplex virus type 2 isolates and stability on passage in cell culture. J Infect Dis 178(1):8–15.
39. Wang Y, et al. (2005) The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest 115(3):711–717.
40. Leib DA, et al. (1989) Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 63(2):759–768.
41. Summers BC, Margolis TP, Leib DA (2001) Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread. J Virol 75(11):5069–5075.